Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Chukwuemeka U Osondu is active.

Publication


Featured researches published by Chukwuemeka U Osondu.


Circulation-cardiovascular Quality and Outcomes | 2016

Favorable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs and Resource Utilization The 2012 Medical Expenditure Panel Survey

Javier Valero-Elizondo; Joseph A Salami; Oluseye Ogunmoroti; Chukwuemeka U Osondu; Ehimen Aneni; Rehan Malik; Erica S. Spatz; Jamal S. Rana; Salim S. Virani; Ron Blankstein; Michael J. Blaha; Emir Veledar; Khurram Nasir

Background—The American Heart Association’s 2020 Strategic Goals emphasize the value of optimizing risk factor status to reduce the burden of morbidity and mortality. In this study, we aimed to quantify the overall and marginal impact of favorable cardiovascular risk factor (CRF) profile on healthcare expenditure and resource utilization in the United States among those with and without cardiovascular disease (CVD). Methods and Results—The study population was derived from the 2012 Medical Expenditure Panel Survey (MEPS). Direct and indirect costs were calculated for all-cause healthcare resource utilization. Variables of interest included CVD diagnoses (coronary artery disease, stroke, peripheral artery disease, dysrhythmias, or heart failure), ascertained by International Classification of Diseases, Ninth Edition, Clinical Modification codes, and CRF profile (hypertension, diabetes mellitus, hypercholesterolemia, smoking, physical activity, and obesity). Two-part econometric models were used to study expenditure data. The final study sample consisted of 15 651 MEPS participants (58.5±12 years, 54% female). Overall, 5921 (37.8%) had optimal, 7002 (44.7%) had average, and 2728 (17.4%) had poor CRF profile, translating to 54.2, 64.1, and 24.9 million adults in United States, respectively. Significantly lower health expenditures were noted with favorable CRF profile across CVD status. Among study participants with established CVD, overall healthcare expenditures with optimal and average CRF profile were


Journal of the American Heart Association | 2016

Economic Impact of Moderate‐Vigorous Physical Activity Among Those With and Without Established Cardiovascular Disease: 2012 Medical Expenditure Panel Survey

Javier Valero-Elizondo; Joseph A Salami; Chukwuemeka U Osondu; Oluseye Ogunmoroti; Alejandro Arrieta; Erica S. Spatz; Adnan Younus; Jamal S. Rana; Salim S. Virani; Ron Blankstein; Michael J. Blaha; Emir Veledar; Khurram Nasir

5946 and


Obesity | 2016

One-year outcomes of an intense workplace cardio-metabolic risk reduction program among high-risk employees: The My Unlimited Potential.

Maribeth Rouseff; Ehimen Aneni; Henry Guzman; Sankalp Das; Doris Brown; Chukwuemeka U Osondu; Erica S. Spatz; Brandon Shaffer; Joann Santiago-Charles; Teresa Ochoa; Joseph Mora; Cynthia Gilliam; Virginia Lehn; Shoshana Sherriff; Thinh Tran; Janisse Post; Emir Veledar; Theodore Feldman; Arthur Agatston; Khurram Nasir

3731 less compared with those with poor CRF profile. The respective differences were


Journal of the American Heart Association | 2017

Estimates of Mortality Benefit From Ideal Cardiovascular Health Metrics: A Dose Response Meta‐Analysis

Ehimen Aneni; Alessio Crippa; Chukwuemeka U Osondu; Javier Valero-Elizondo; Adnan Younus; Khurram Nasir; Emir Veledar

4031 and


Vascular Medicine | 2017

The relationship of erectile dysfunction and subclinical cardiovascular disease: A systematic review and meta-analysis

Chukwuemeka U Osondu; Bryan Vo; Ebenezer Oni; Michael J. Blaha; Emir Veledar; Theodore Feldman; Arthur Agatston; Khurram Nasir; Ehimen Aneni

2560 in those without CVD. Conclusions—Favorable CRF profile is associated with significantly lower medical expenditure and healthcare utilization among individuals with and without established CVD.


Mayo Clinic Proceedings | 2017

Favorable Cardiovascular Health Is Associated With Lower Health Care Expenditures and Resource Utilization in a Large US Employee Population: The Baptist Health South Florida Employee Study

Chukwuemeka U Osondu; Ehimen Aneni; Javier Valero-Elizondo; Joseph A Salami; Maribeth Rouseff; Sankalp Das; Henry Guzman; Adnan Younus; Oluseye Ogunmoroti; Theodore Feldman; Arthur Agatston; Emir Veledar; Barry T. Katzen; Chris Calitz; Eduardo Sanchez; Donald M. Lloyd-Jones; Khurram Nasir

Background Physical activity (PA) has an established favorable impact on cardiovascular disease (CVD) outcomes and quality of life. In this study, we aimed to estimate the economic effect of moderate‐vigorous PA on medical expenditures and utilization from a nationally representative cohort with and without CVD. Methods and Results The 2012 Medical Expenditure Panel Survey data were analyzed. Our study population was limited to noninstitutionalized US adults ≥18 years of age. Variables of interest included CVD (coronary artery disease, stroke, heart failure, dysrhythmias, or peripheral artery disease) and cardiovascular modifiable risk factors (CRFs; hypertension, diabetes mellitus, hypercholesterolemia, smoking, and/or obesity). Two‐part econometric models were utilized to study cost data; a generalized linear model with gamma distribution and link log was used to assess expenditures per capita. The final study sample included 26 239 surveyed individuals. Overall, 47% engaged in moderate‐vigorous PA ≥30 minutes, ≥5 days/week, translating to 111.5 million adults in the United States stratifying by CVD status; 32% reported moderate‐vigorous PA among those with CVD versus 49% without CVD. Generally, participants reporting moderate‐vigorous PA incurred significantly lower health care expenditures and resource utilization, displaying a step‐wise lower total annual health care expenditure as moving from CVD to non‐CVD (and each CRF category). Conclusions Moderate‐vigorous PA ≥30 minutes, ≥5 days/week is associated with significantly lower health care spending and resource utilization among individuals with and without established CVD.


Journal of Atherosclerosis and Thrombosis | 2018

Lipoprotein Sub-Fractions by Ion-Mobility Analysis and Its Association with Subclinical Coronary Atherosclerosis in High-Risk Individuals

Ehimen C Aneni; Chukwuemeka U Osondu; Javier De La Cruz; Seth S. Martin; Michael J. Blaha; Adnan Younus; Theodore Feldman; Arthur Agatston; Emir Veledar; Khurram Nasir

This study details 6‐ and 12‐month cardio‐metabolic outcomes of an intense 12‐week workplace lifestyle intervention program, the My Unlimited Potential (MyUP), conducted in a large healthcare organization.


Mayo Clinic Proceedings | 2016

A Systematic Review of the Prevalence and Outcomes of Ideal Cardiovascular Health in US and Non-US Populations

Adnan Younus; Ehimen Aneni; Erica S. Spatz; Chukwuemeka U Osondu; Lara Roberson; Oluseye Ogunmoroti; Rehan Malik; Shozab S. Ali; Muhammad Aziz; Theodore Feldman; Salim S. Virani; Wasim Maziak; Arthur Agatston; Emir Veledar; Khurram Nasir

Background Several studies have shown an inverse relationship between ideal cardiovascular health (CVH) and mortality. However, there are no studies that pool these data to show the shape of the relationship and quantify the mortality benefit from ideal CVH. Methods and Results We conducted a systematic internet literature search of multiple databases including MEDLINE, Web of Science, Embase, CINAHL, and Scopus for longitudinal studies assessing the relationship between ideal CVH and mortality in adults, published between January 1, 2010, and May 31, 2017. We included studies that assessed the relationship between ideal CVH and mortality in populations that were initially free of cardiovascular disease. We conducted a dose‐response meta‐analysis generating both study‐specific and pooled trends from the correlated log hazard ratio estimates of mortality across categories of ideal CVH metrics. A total of 6 studies were included in the meta‐analysis. All of the studies indicated a linear decrease in (cardiovascular disease and all‐cause) mortality with increasing ideal CVH metrics. Overall, each unit increase in CVH metrics was associated with a pooled hazard ratio for cardiovascular disease mortality of 0.81 (95% confidence interval, 0.75–0.87), while each unit increase in ideal CVH metrics was associated with a pooled hazard ratio of 0.89 (95% confidence interval, 0.86–0.93) for all‐cause mortality. Conclusions Our meta‐analysis showed a strong inverse linear dose‐response relationship between ideal CVH metrics and both all‐cause and cardiovascular disease–related mortality. This study suggests that even modest improvements in CVH is associated with substantial mortality benefit, thus providing a strong public health message advocating for even the smallest improvements in lifestyle.


Journal of the American College of Cardiology | 2015

Prevalence of Ideal Cardiovascular Health Among Adults in the United States.

Adnan Younus; Ehimen Aneni; Erica S. Spatz; Chukwuemeka U Osondu; Sameer Shaharyar; Lara Roberson; Shozab S. Ali; Oluseye Ogunmoroti; Rameez Ahmad; Janisse Post; Ted Feldman; Wasim Maziak; Arthur Agatston; Emir Veledar; Khurram Nasir

Erectile dysfunction (ED) is associated with cardiovascular disease (CVD) and CVD mortality. However, the relationship between ED and subclinical CVD is less clear. We synthesized the available data on the association of ED and measures of subclinical CVD. We searched multiple databases for published literature on studies examining the association of ED and measures of subclinical CVD across four domains: endothelial dysfunction measured by flow-mediated dilation (FMD), carotid intima–media thickness (cIMT), coronary artery calcification (CAC), and other measures of vascular function such as the ankle–brachial index, toe–brachial index, and pulse wave velocity. We conducted random effects meta-analysis and meta-regression on studies that examined an ED relationship with FMD (15 studies; 2025 participants) and cIMT (12 studies; 1264 participants). ED was associated with a 2.64 percentage-point reduction in FMD compared to those without ED (95% CI: –3.12, −2.15). Persons with ED also had a 0.09-mm (95% CI: 0.06, 0.12) higher cIMT than those without ED. In subgroup meta-analyses, the mean age of the study population, study quality, ED assessment questionnaire (IIEF-5 or IIEF-15), or the publication date did not significantly affect the relationship between ED and cIMT or between ED and FMD. The results for the association of ED and CAC were inconclusive. In conclusion, this study confirms an association between ED and subclinical CVD and may shed additional light on the shared mechanisms between ED and CVD, underscoring the importance of aggressive CVD risk assessment and management in persons with ED.


Progress in Pediatric Cardiology | 2016

Prevalence of ideal cardiovascular health metrics in children & adolescents: A systematic review

Justin M. Pacor; Adnan Younus; Rehan Malik; Chukwuemeka U Osondu; Muhammad Aziz; Oluseye Ogunmoroti; Muhammad Amir Younus; Ehimen Aneni; Erica S. Spatz; Choudhry Humayun; Salim S. Virani; Michael J. Blaha; Khurram Nasir

Objective: To examine the association of favorable cardiovascular health (CVH) status with 1‐year health care expenditures and resource utilization in a large health care employee population. Participants and Methods: Employees of Baptist Health South Florida participated in a health risk assessment from January 1 through September 30, 2014. Information on dietary patterns, physical activity, blood pressure, blood glucose level, total cholesterol level, and smoking were collected. Participants were categorized into CVH profiles using the American Heart Associations ideal CVH construct as optimal (6–7 metrics), moderate (3–5 metrics), and low (0–2 metrics). Two‐part econometric models were used to analyze health care expenditures. Results: Of 9097 participants (mean ± SD age, 42.7±12.1 years), 1054 (11.6%) had optimal, 6945 (76.3%) had moderate, and 1098 (12.1%) had low CVH profiles. The mean annual health care expenditures among those with a low CVH profile was

Collaboration


Dive into the Chukwuemeka U Osondu's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Emir Veledar

Baptist Hospital of Miami

View shared research outputs
Top Co-Authors

Avatar

Ehimen Aneni

Baptist Hospital of Miami

View shared research outputs
Top Co-Authors

Avatar

Arthur Agatston

Baptist Hospital of Miami

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Adnan Younus

Baptist Hospital of Miami

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sankalp Das

Baptist Hospital of Miami

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge